Literature DB >> 1829416

Differential regulation of antigen presentation in high- and low-IgE responder mice.

L V Rizzo1, D T Umetsu, R H DeKruyff.   

Abstract

Strains of mice differ greatly in their capacity to produce interleukin (IL) 4 and high levels of serum IgE. The contribution of macrophages (M phi) in enhancing the production of IL4 by T cells in high-IgE responder mice was studied. M phi from BALB/c mice (high-IgE responder strain) developed an augmented capacity to present antigen to IL 4-producing T helper type 2 (Th2) clones, when the M phi were pretreated by exposure to the lymphokines IL 4 and IL 5. In contrast, identical treatment of M phi from H-2-identical DBA/2 mice (low-IgE responder strain) resulted in inhibition of the capacity to stimulate Th2 clones. The impairment of antigen presentation by DBA/2 M phi was closely paralleled by a decrease of cell surface class II major histocompatibility complex (MHC) expression and an abrogation of IL 1 production by these cells, while identical treatment of BALB/c M phi enhanced class II MHC expression and did not inhibit secretion of IL 1. Our studies demonstrate that IL 4 and IL 5 can exert different effects on M phi from high- and low-IgE responder strains of mice, resulting in down-regulation of the expansion of IL 4-producing cells in low-but not high-IgE responder mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1829416     DOI: 10.1002/eji.1830210729

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Ocular surface epithelium induces expression of human mucosal lymphocyte antigen (HML-1) on peripheral blood lymphocytes.

Authors:  J A P Gomes; H S Dua; L V Rizzo; M Nishi; A Joseph; L A Donoso
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

2.  Functional heterogeneity of human T cell clones from atopic and non-atopic donors.

Authors:  C A Chambers; B Zimmerman; N Hozumi
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

3.  Development of CD4+ T cell lines that suppress an antigen-specific immune response in vivo.

Authors:  L Vieira de Moraes; B Sun; L V Rizzo
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.